Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3507-18-4

Post Buying Request

3507-18-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3507-18-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3507-18-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,0 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3507-18:
(6*3)+(5*5)+(4*0)+(3*7)+(2*1)+(1*8)=74
74 % 10 = 4
So 3507-18-4 is a valid CAS Registry Number.

3507-18-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Methyl-1,3-benzothiazole-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-Benzothiazolecarboxylicacid,6-methyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3507-18-4 SDS

3507-18-4Relevant articles and documents

Synthesis of novel cycloheptylbenzothiazole-2-carboxamides and biological evaluation as human estrogen receptor modulators

Kapse, Purushottam,Chikhale, Rupesh V.,Khan, Mohammad Rizwan,Wabaidur, Saikh M.,Islam, Md Ataul

, (2021)

Background: Bladder cancer is one of the deadly cancer with 16,390 deaths in 2015-16 alone and 76,960 new cases. The matter of concern is more severe with very limited options of treatment and lack of new drugs, cisplatin and doxorubicin are the only two drugs mostly used in therapy. This situation along with the epidemiological data calls for the development of newer better and safer agents. Herein, we report nine novel benzothiazole derivatives based on structure-based drug discovery and molecular modelling approaches. Material and methods: Newly designed compounds were synthesized following a four-step reaction and were characterized for structural confirmation. These novel compounds were evaluated on the MTT assay for their in vitro efficiency using the TCP1020 cell lines. These were further analysed for their mechanism of action based on in silico studies. Results: Two compounds of the series exhibit promising results which are in agreement with the in-silico studies. It was found that the methyl group at the seventh position to the nitrogen decreases the electron affinity of the series and is thus responsible for the activity in 4e. The methyl substituted compound 4e and fluoro substituted compound 4i shows the highest activities with an IC50 of 10.1 ± 0.2 and 7.8 ± 0.7 respectively.

Carbon dioxide as the C1 source for direct C-H functionalization of aromatic heterocycles

Vechorkin, Oleg,Hirt, Nathalie,Hu, Xile

supporting information; experimental part, p. 3567 - 3569 (2010/10/02)

(Equation Presented). A simple and straightforward method has been developed for the direct carboxylation of aromatic heterocylces such as oxazoles, thiazoles, and oxadiazoles using CO2 as the C1 source. The reactions require no metal catalyst and only Cs2CO3 as the base. A good functional group tolerance is achieved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3507-18-4